BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• SRI/Surgical Express, Inc. Adopts Shareholder Rights Plan

  November 8, 2010

   · 

  1 min read
• BioMidwest

  Abbott Laboratories Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA

  November 8, 2010

   · 

  5 min read
• Business

  PuriCore Q3 2010 Interim Management Statement

  November 8, 2010

   · 

  7 min read
• Deals

  VIVUS, Inc. Announces Closing of MUSE Sale

  November 8, 2010

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company Release: New Data Show That Subcutaneous Injection of an Investigational Formulation of ORENCIA(R) (abatacept) Provided Similar Improvements in Disease Activity Compared to Intravenous Administration of ORENCIA

  November 8, 2010

   · 

  1 min read
• Business

  Biotel Inc. Announces Definitive Merger Agreement With CardioNet, Inc. for $11 Million

  November 8, 2010

   · 

  7 min read
• Deals

  Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering

  November 8, 2010

   · 

  2 min read
• Deals

  VIVUS, Inc. Sells Muse Assets For $23.5M to Meda AB

  November 8, 2010

   · 

  1 min read
• Business

  Vascular Pathways Hires Eugene Starr as President and CEO, Moves HQ

  November 8, 2010

   · 

  2 min read
• Business

  XenoPort, Inc. Amends Agreement With GlaxoSmithKline On RLS Drug, Horizant; Milestone Payments Changed; Xenoport Reacquires Rights Outside of the U.S.

  November 8, 2010

   · 

  1 min read